How strong is the foundation for EMTT?

Start with the type of claim

Not every ruling on EMTT asks for the same evidence. The fact that a device generates an electromagnetic field is a technical feature. The fact that people experience less pain is a clinical outcome. That damaged tissue completely recovers is another claim.

These levels are sometimes used interchangeably in advertising. A plausible biological mechanism may be interesting, but does not automatically predict the effect in patients. For a treatment choice you especially want to know what people with a similar symptom could achieve.

Ask therefore what outcome is meant by words such as recovery, regeneration or success. If the answer is only about a supposed cell process, it has not yet been explained how much clinical added value has been demonstrated.

What does placebo-controlled study add?

A placebo group helps to compare the effect of an active application with as similar treatment experience as possible. With this you try to keep other influences, such as attention and expectations, better apart.

The study of Dutchman and colleagues EMTT compared with placebo in 126 subjects with different musculoskeletal diagnoses. There were favorable group outcomes for pain and physical function up to 12 weeks. That's a relevant research signal.

The mixed group does require caution. A positive overall result is not automatically a separate confirmation for each diagnosis in the group. Nor can we deduce how the effect develops in the long term or how EMTT relates to any other treatment.

Combination study asks another question

The research by Klüter from 2018 Investigated addition of EMTT to focused shockwave in long-term non-calcified rotator cufftendinopathy. Both groups also received physiotherapy. Thus, the comparison was not about EMTT as a loose replacement of active treatment.

Such design may provide guidance on the addition within that programme. It does not prove that EMTT is always needed in addition to shockwave or that radial treatment has the same combination outcome. Other research questions should be examined.

There is also a need for caution in the word synergy. Without sufficient comparison of the individual components, one cannot establish that the techniques are biologically reinforcing each other. A favourable combination result and a proven mechanism are different conclusions.

Place separate studies next to guidelines

A guideline weighs more than one result. The JOSPT guideline from 2025 recommends against shockwave for non-calcific rotator cuff tendinopathy. This remains relevant when discussing combined treatment based on the Klüter study.

A new or positive study may give rise to further study, but does not automatically change all the recommendations. The treatment proposal should explain why an application is being considered and what uncertainty remains.

For you, it is useful to ask whether the proposed care is generally recommended, an additional possibility with limited data or an application with little clinical evidence. This distinction helps to balance expectations and costs better.

Four boundaries that remain visible in a good explanation

In addition, observe independent repetition and the role of interested parties. A manufacturer can provide useful technical information, but also has an interest in using the device. This means that promotional explanations do not have the same probative force as carefully conducted clinical trials.

A limited publication doesn't have to be worthless. The appropriate conclusion is often smaller than the advertising claim: there is an interesting signal that needs to be investigated further.

How do you translate uncertainty into a decision?

Uncertainty is not just for researchers. It affects how much time and money you want to spend on an additional treatment and what result you reasonably expect. Therefore, discuss possible benefits and the scenario in which little changes.

Choose a recognizable activity to follow in advance. Ask when the supplement is evaluated and when it does not make enough sense to continue. A limited consideration is better to assess than an open range without clear targets.

Your personal experience remains valuable, but doesn't prove anything to anyone. When you improve, that may be recognized without making a universal claim. If you don't improve, the plan should be able to change without being blamed for failing.